There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

ScienceOpen disciplines: Oncology & Radiotherapy, Medicine

Comments

Comment on this article

Cited by 1

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer
Authors: J Feliu, A Salud, P. Escudero …

See all cited by

Phase II, randomized, open-label study of capecitabine (X) plus oxaliplatin (XELOX) vs infusional 5-FU/LV plus oxaliplatin (FOLFOX-6) first-line treatment in patients (pts) with metastatic colorectal cancer (MCRC): findings from an interim safety analysis

Read this article at

Related collections

Karger: Oncology

Comments

Comment on this article

Similar content 684

Cited by 1